Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study
风险适应性、基于奥法妥木单抗的化疗免疫疗法和巩固疗法治疗初治慢性淋巴细胞白血病:一项 II 期研究
期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.1080/10428194.2021.1888379
Desai, Sanjal; Mo, Clifton; Gaglione, Erika M; Yuan, Constance M; Stetler-Stevenson, Maryalice; Tian, Xin; Maric, Irina; Wake, Laura; Farooqui, Mohammed Z; Drinkwater, Dennis C; Soto, Susan; Valdez, Janet; Hughes, Thomas E; Nierman, Pia; Lotter, Jennifer; Marti, Gerald E; Pleyer, Christopher; Sun, Clare; Superata, Jeanine; Nichols, Cydney; Herman, Sarah E M; Lindorfer, Margaret A; Taylor, Ronald P; Wiestner, Adrian; Ahn, Inhye E